Total Payments
$52,010
2024 Payments
$1,760
Companies
7
Transactions
84
Payment Breakdown by Category
Other$39,427 (75.8%)
Travel$11,509 (22.1%)
Food & Beverage$1,074 (2.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $39,427 | 14 | 75.8% |
| Travel and Lodging | $11,509 | 39 | 22.1% |
| Food and Beverage | $1,074 | 31 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Shire North American Group Inc | $33,373 | 50 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $18,332 | 23 | $0 (2024) |
| Medtronic, Inc. | $167.32 | 2 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $86.08 | 5 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $28.14 | 2 | $0 (2019) |
| Smith & Nephew, Inc. | $12.58 | 1 | $0 (2018) |
| AcelRx Pharmaceuticals, Inc. | $11.18 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,760 | 6 | Takeda Pharmaceuticals U.S.A., Inc. ($1,744) |
| 2023 | $6,819 | 8 | Takeda Pharmaceuticals U.S.A., Inc. ($6,668) |
| 2022 | $621.87 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($621.87) |
| 2021 | $7,573 | 5 | Takeda Pharmaceuticals U.S.A., Inc. ($7,573) |
| 2020 | $1,736 | 3 | Takeda Pharmaceuticals U.S.A., Inc. ($1,725) |
| 2019 | $6,493 | 10 | Shire North American Group Inc ($6,479) |
| 2018 | $15,290 | 26 | Shire North American Group Inc ($15,213) |
| 2017 | $11,717 | 22 | Shire North American Group Inc ($11,681) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $80.40 | General |
| 12/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $56.00 | General |
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $1,024.89 | General |
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $381.65 | General |
| 11/08/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $200.76 | General |
| 07/31/2024 | Medtronic, Inc. | NUVENT (Device) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Sinus Surgery | ||||||
| 12/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Travel and Lodging | In-kind items and services | $98.26 | General |
| Category: GENETIC DISEASE | ||||||
| 12/01/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Travel and Lodging | In-kind items and services | $28.00 | General |
| Category: GENETIC DISEASE | ||||||
| 11/27/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,363.13 | General |
| Category: GENETIC DISEASE | ||||||
| 11/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Travel and Lodging | In-kind items and services | $806.98 | General |
| Category: GENETIC DISEASE | ||||||
| 11/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Travel and Lodging | In-kind items and services | $664.60 | General |
| Category: GENETIC DISEASE | ||||||
| 11/13/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Food and Beverage | In-kind items and services | $35.83 | General |
| Category: GENETIC DISEASE | ||||||
| 10/11/2023 | Medtronic, Inc. | Sinuva (Drug) | Food and Beverage | In-kind items and services | $150.70 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 08/16/2023 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $671.25 | General |
| Category: GENETIC DISEASE | ||||||
| 09/12/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $515.00 | General |
| Category: GENETIC DISEASE | ||||||
| 01/24/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Travel and Lodging | In-kind items and services | $60.48 | General |
| Category: GENETIC DISEASE | ||||||
| 01/24/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: GENETIC DISEASE | ||||||
| 01/24/2022 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Food and Beverage | In-kind items and services | $21.35 | General |
| Category: GENETIC DISEASE | ||||||
| 12/21/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,893.00 | General |
| Category: GENETIC DISEASE | ||||||
| 12/03/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Travel and Lodging | In-kind items and services | $622.17 | General |
| Category: GENETIC DISEASE | ||||||
| 12/02/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Travel and Lodging | In-kind items and services | $135.75 | General |
| Category: GENETIC DISEASE | ||||||
| 06/28/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $772.50 | General |
| Category: GENETIC DISEASE | ||||||
| 03/22/2021 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: GENETIC DISEASE | ||||||
| 12/21/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,150.00 | General |
| Category: GENETIC DISEASE | ||||||
| 09/04/2020 | Takeda Pharmaceuticals U.S.A., Inc. | ELAPRASE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $575.00 | General |
| Category: GENETIC DISEASE | ||||||
About Dr. David Karas, MD
Dr. David Karas, MD is a Pediatric Otolaryngology healthcare provider based in Madison, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/24/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386604296.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Karas, MD has received a total of $52,010 in payments from pharmaceutical and medical device companies, with $1,760 received in 2024. These payments were reported across 84 transactions from 7 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($39,427).
Ad
Practice Information
- Specialty Pediatric Otolaryngology
- Other Specialties Sleep Medicine, Pediatrics
- Location Madison, CT
- Active Since 03/24/2006
- Last Updated 12/18/2013
- Taxonomy Code 207YP0228X
- Entity Type Individual
- NPI Number 1386604296
Products in Payments
- ELAPRASE (Biological) $49,961
- Sinuva (Drug) $150.70
- Otovel (Drug) $50.34
- Evekeo (Drug) $35.74
- CIPRODEX (Drug) $28.14
- NUVENT (Device) $16.62
- Coblation - Tonsil Wands (Device) $12.58
- DSUVIA (Drug) $11.18
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.